New drug combination before cell therapy for advanced blood cancer

This study is testing a new drug called aponermin as a preparation treatment before CAR-T cell therapy for patients with multiple myeloma that has come back after previous treatment or stopped responding to treatment. The myeloma in this trial has spread outside the bone marrow to soft tissues—a more serious form of the disease. Researchers want to see if this medication helps make the CAR-T cell therapy (a personalized immune cell treatment) work better and is safe for patients.

Multiple myeloma that spreads outside the bone marrow is harder to treat and more aggressive. This trial exists to find better ways to prepare patients for CAR-T cell therapy, which is a promising but complex treatment. The new medication may help control the disease before the main cell therapy begins, potentially improving outcomes for patients with this difficult-to-treat form of cancer.